vs
Side-by-side financial comparison of COLONY BANKCORP INC (CBAN) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $39.9M, roughly 1.6× COLONY BANKCORP INC). COLONY BANKCORP INC runs the higher net margin — 20.6% vs -70.9%, a 91.5% gap on every dollar of revenue. Over the past eight quarters, COLONY BANKCORP INC's revenue compounded faster (19.6% CAGR vs 17.7%).
Colony Bankcorp Inc is a US-based bank holding company that operates Colony Bank. It provides a full suite of personal and commercial banking services including deposit accounts, consumer and business loans, mortgage services, and wealth management solutions, primarily serving retail customers and small-to-medium enterprises across the state of Georgia.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
CBAN vs CTKB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.9M | $62.1M |
| Net Profit | $8.2M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | — | -9.0% |
| Net Margin | 20.6% | -70.9% |
| Revenue YoY | — | 8.1% |
| Net Profit YoY | 24.1% | -557.1% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $39.9M | — | ||
| Q4 25 | $36.9M | $62.1M | ||
| Q3 25 | $32.8M | $52.3M | ||
| Q2 25 | $32.5M | $45.6M | ||
| Q1 25 | $30.0M | $41.5M | ||
| Q4 24 | $30.8M | $57.5M | ||
| Q3 24 | $28.6M | $51.5M | ||
| Q2 24 | $27.9M | $46.6M |
| Q1 26 | $8.2M | — | ||
| Q4 25 | — | $-44.1M | ||
| Q3 25 | $5.8M | $-5.5M | ||
| Q2 25 | $8.0M | $-5.6M | ||
| Q1 25 | $6.6M | $-11.4M | ||
| Q4 24 | — | $9.6M | ||
| Q3 24 | $5.6M | $941.0K | ||
| Q2 24 | $5.5M | $-10.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 54.6% |
| Q1 26 | — | — | ||
| Q4 25 | 25.9% | -9.0% | ||
| Q3 25 | 22.2% | -17.6% | ||
| Q2 25 | 30.9% | -23.3% | ||
| Q1 25 | 27.6% | -36.1% | ||
| Q4 24 | 28.8% | 5.2% | ||
| Q3 24 | 24.6% | -8.2% | ||
| Q2 24 | 24.8% | -18.3% |
| Q1 26 | 20.6% | — | ||
| Q4 25 | — | -70.9% | ||
| Q3 25 | 17.7% | -10.5% | ||
| Q2 25 | 24.6% | -12.2% | ||
| Q1 25 | 22.0% | -27.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | 19.7% | 1.8% | ||
| Q2 24 | 19.6% | -22.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.42 | — | ||
| Q3 25 | $0.33 | — | ||
| Q2 25 | $0.46 | — | ||
| Q1 25 | $0.38 | — | ||
| Q4 24 | $0.43 | — | ||
| Q3 24 | $0.32 | — | ||
| Q2 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $295.8M | $90.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $380.4M | $341.7M |
| Total Assets | $3.7B | $461.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $295.8M | — | ||
| Q4 25 | — | $90.9M | ||
| Q3 25 | — | $93.3M | ||
| Q2 25 | — | $75.5M | ||
| Q1 25 | — | $95.3M | ||
| Q4 24 | — | $98.7M | ||
| Q3 24 | — | $162.3M | ||
| Q2 24 | — | $177.9M |
| Q1 26 | — | — | ||
| Q4 25 | $258.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $248.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $380.4M | — | ||
| Q4 25 | $375.9M | $341.7M | ||
| Q3 25 | $302.3M | $378.6M | ||
| Q2 25 | $293.9M | $377.6M | ||
| Q1 25 | $286.9M | $379.6M | ||
| Q4 24 | $278.7M | $395.7M | ||
| Q3 24 | $276.1M | $385.5M | ||
| Q2 24 | $264.7M | $389.1M |
| Q1 26 | $3.7B | — | ||
| Q4 25 | $3.7B | $461.5M | ||
| Q3 25 | $3.2B | $494.9M | ||
| Q2 25 | $3.1B | $493.3M | ||
| Q1 25 | $3.2B | $482.6M | ||
| Q4 24 | $3.1B | $499.5M | ||
| Q3 24 | $3.1B | $491.2M | ||
| Q2 24 | $3.0B | $483.7M |
| Q1 26 | — | — | ||
| Q4 25 | 0.69× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.89× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-5.5M | $-771.0K | ||
| Q3 25 | $14.4M | $-3.9M | ||
| Q2 25 | $15.8M | $108.0K | ||
| Q1 25 | $17.9M | $-125.0K | ||
| Q4 24 | $23.4M | $2.0M | ||
| Q3 24 | $20.5M | $13.2M | ||
| Q2 24 | $1.1M | $6.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.9M | $-1.8M | ||
| Q3 25 | $14.1M | $-4.6M | ||
| Q2 25 | $15.8M | $-1.5M | ||
| Q1 25 | $17.6M | $-974.0K | ||
| Q4 24 | $22.3M | $1.1M | ||
| Q3 24 | $20.2M | $12.2M | ||
| Q2 24 | $990.0K | $5.2M |
| Q1 26 | — | — | ||
| Q4 25 | -18.7% | -2.9% | ||
| Q3 25 | 42.9% | -8.7% | ||
| Q2 25 | 48.5% | -3.2% | ||
| Q1 25 | 58.7% | -2.3% | ||
| Q4 24 | 72.5% | 1.9% | ||
| Q3 24 | 70.6% | 23.7% | ||
| Q2 24 | 3.5% | 11.0% |
| Q1 26 | — | — | ||
| Q4 25 | 3.7% | 1.6% | ||
| Q3 25 | 1.1% | 1.3% | ||
| Q2 25 | 0.3% | 3.5% | ||
| Q1 25 | 1.2% | 2.0% | ||
| Q4 24 | 3.5% | 1.6% | ||
| Q3 24 | 1.0% | 2.0% | ||
| Q2 24 | 0.5% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.48× | — | ||
| Q2 25 | 1.99× | — | ||
| Q1 25 | 2.71× | — | ||
| Q4 24 | — | 0.21× | ||
| Q3 24 | 3.64× | 14.05× | ||
| Q2 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAN
| Net Interest Income | $29.2M | 73% |
| Noninterest Income | $10.7M | 27% |
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
